Kunioka Shingo, Shirasaka Tomonori, Miyamoto Hiroyuki, Shibagaki Keisuke, Kikuchi Yuta, Akasaka Nobuyuki, Kamiya Hiroyuki
Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, JPN.
Department of Cardiovascular Surgery, Steel Memorial Muroran Hospital, Muroran, JPN.
Cureus. 2022 Feb 21;14(2):e22474. doi: 10.7759/cureus.22474. eCollection 2022 Feb.
Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the "early ECMO group," VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the "late ECMO group," VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients' 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required.
心脏术后心源性休克(PCS)是心脏手术中最危急的情况之一。最近,对于PCS患者,建议早期启动静脉-动脉体外膜肺氧合(VA-ECMO)以确保终末器官灌注,尤其是在大容量中心。在本研究中,我们调查了在小容量中心更早启动VA-ECMO治疗PCS的有效性。方法:我们回顾性评估了2014年4月至2019年3月期间在我们两个相关机构收治的患者。纳入在心脏手术围术期或术后(48小时内)接受VA-ECMO治疗的患者。根据VA-ECMO启动时间将患者分为两组。在VA-ECMO早期启动组,即“早期ECMO组”,当患者需要高剂量的正性肌力支持,如使用高剂量的儿茶酚胺(如肾上腺素)时,不等PCS恢复就启动VA-ECMO。在VA-ECMO晚期启动组,即“晚期ECMO组”,VA-ECMO延迟至PCS不能被高剂量儿茶酚胺控制时启动,目的是避免严重出血并发症。结果:共有30例患者纳入分析(早期ECMO组/晚期ECMO组:19/11例患者)。整个队列的30天死亡率为60%(n = 18),两组之间无显著差异(早期ECMO组/晚期ECMO组:64%/55%,p = 0.712)。早期ECMO组(43%)和晚期ECMO组(55%)分别有13例和6例患者未脱机死亡;两组之间无显著差异(p = 0.696)。ECMO支持的中位持续时间为5天(IQR:1.5 - 6.5)。结论:在小容量中心,早期启动ECMO对患者30天结局无贡献。为改善PCS患者的ECMO治疗结局,可能需要小容量中心集中化。